Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 20, 2016 08:30 ET | Source: SteadyMed Therapeutics

SteadyMed to Present at the Annual Ladenburg Thalmann 2016 Healthcare Conference

SAN RAMON, Calif., Sept. 20, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and...
September 06, 2016 11:36 ET | Source: SteadyMed Therapeutics

SteadyMed to Present at the 18th Annual Rodman & Renshaw Global Investment Conference

SAN RAMON, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and...
September 01, 2016 08:30 ET | Source: SteadyMed Therapeutics

SteadyMed Announces Completion of Pre-NDA Submission Manufacturing Activities

SAN RAMON, Calif., Sept. 01, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and...
August 15, 2016 17:09 ET | Source: SteadyMed Therapeutics

SteadyMed Provides Corporate Update and Reports Second Quarter 2016 Financial Results

SAN RAMON, Calif., Aug. 15, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and...
July 29, 2016 15:04 ET | Source: SteadyMed Therapeutics

SteadyMed Raises up to $32 Million in Private Placement

SAN RAMON, Calif., July 29, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and...
June 21, 2016 09:00 ET | Source: SteadyMed Therapeutics

SteadyMed to Present at the 2016 JMP Securities Life Sciences Conference

SAN RAMON, Calif., June 21, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and...
June 17, 2016 09:56 ET | Source: SteadyMed Therapeutics

UPDATE -- SteadyMed and the Pulmonary Hypertension Association Launch Campaign to Highlight Unique and Inspirational Faces Behind PH

SAN RAMON, Calif., June 17, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and...
June 16, 2016 08:39 ET | Source: SteadyMed Therapeutics

SteadyMed and the Pulmonary Hypertension Association Launch Campaign to Highlight Unique and Inspirational Faces Behind PH

SAN RAMON, Calif., June 16, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and...
May 11, 2016 08:30 ET | Source: SteadyMed Therapeutics

SteadyMed Provides Corporate Update and Reports First Quarter 2016 Financial Results

SAN RAMON, Calif., May 11, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and...
April 25, 2016 08:30 ET | Source: SteadyMed Therapeutics

SteadyMed Announces Public Availability of PTAB Decision to Institute Inter Partes Review Proceedings

SAN RAMON, Calif., April 25, 2016 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right